Armstrong Advisory Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57K Hold
65
﹤0.01% 760
2026
Q1
$6.29K Hold
65
﹤0.01% 762
2025
Q4
$6.9K Hold
65
﹤0.01% 733
2025
Q3
$8.26K Hold
65
﹤0.01% 715
2025
Q2
$7.97K Hold
65
﹤0.01% 706
2025
Q1
$6K Hold
65
﹤0.01% 675
2024
Q4
$6K Hold
65
﹤0.01% 675
2024
Q3
$6.28K Hold
65
﹤0.01% 643
2024
Q2
$5.58K Hold
65
﹤0.01% 644
2024
Q1
$4.34K Hold
65
﹤0.01% 655
2023
Q4
$4.34K Sell
65
-51
-44% -$3.3K ﹤0.01% 655
2023
Q3
$7.79K Buy
116
+51
+78% +$3.51K ﹤0.01% 645
2023
Q2
$4.4K Hold
65
﹤0.01% 678
2023
Q1
$3.52K Hold
65
﹤0.01% 672
2022
Q4
$3.89K Buy
+65
New +$3.54K ﹤0.01% 688

Other funds holding EHC

Armstrong Advisory Group's EHC Position: Q2 2026 in Review

Armstrong Advisory Group held its Encompass Health (EHC) position steady in Q2 2026 at 65 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Armstrong Advisory Group first reported a position in EHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.26K in Q3 2025. 54 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Armstrong Advisory Group held 65 shares of Encompass Health worth $6.57K as of Q2 2026.
  • Armstrong Advisory Group left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #760 holding.
  • Armstrong Advisory Group first reported a position in Encompass Health in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Encompass Health position peaked at $8.26K in Q3 2025.
  • 54 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.